DUBLIN--(BUSINESS WIRE)--The "CRO Quality Benchmarking - Phase IV Service Providers (9th Edition)" report has been added to Research and Markets' offering.
ISR's CRO Quality Benchmarking - Phase IV Service Providers (9th Edition) report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their experiences with 24 Phase IV CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 9th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.
What You Will Learn:
- Make a more informed purchase of Phase IV services by understanding which service providers best fit your company's needs
- Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes
- Pinpoint potential delivery concerns early in a sponsor
- CRO relationship in order to develop proactive strategies to address potential gaps
Key Topics Covered:
1. Introduction
2. Methodology
3. Respondent Demographics and Qualifications
Number of Ratings per Company
5 Major Sections
4. Service Provider Selection Process
Primary Section Takeaways
5. Service Provider Perceptions And Interactions
6. Service Provider Performance And Loyalty
Primary Section Takeaways
Rolling Average
7. Company Service Quality Profiles
Covance
ICON
INC Research
Mapi
PAREXEL
PPD
PRA
Quintiles
8. Study Data
Phase IV Leaders, Unprompted
Phase IV Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Selection Drivers: Selecting among
Preferred Providers
Preferred Provider Attributes
Gaining Importance
Selection Drivers When Not Using
Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance:
No Preferred Providers
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
9. Service Provider Drill-Downs
Accenture
Bioclinica
Chiltern
Cognizant
Covance
DaVita Clinical Research
DCRI-Duke
ICON
INC Research
inVentiv Health Clinical
Lambda
Mapi
Medpace
NAMSA
Novotech
PAREXEL
PPD
PRA
Quintiles
SGS Life Sciences
Tat a
TKL Research
UBC
Worldwide Clinical Trials
Performance Across Service Providers
10. Demographics
Company Size
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age
For more information about this report visit https://www.researchandmarkets.com/research/pc44zk/cro_quality